DEXAMETHASONE SODIUM PHOSPHATE 0.1% / FINASTERIDE 0.1% / MINOXIDIL 5% / TRETINOIN 0.025% is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida. The primary component is Dexamethasone Sodium Phosphate; Finasteride; Minoxidil; Tretinoin.
| Product ID | 72934-4070_88612151-53b3-b592-e053-2995a90a0025 |
| NDC | 72934-4070 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DEXAMETHASONE SODIUM PHOSPHATE 0.1% / FINASTERIDE 0.1% / MINOXIDIL 5% / TRETINOIN 0.025% |
| Generic Name | Dexamethasone Sodium Phosphate 0.1% / Finasteride 0.1% / Minoxidil 5% / Tretinoin 0.025% |
| Dosage Form | Solution |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-05-09 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Sincerus Florida |
| Substance Name | DEXAMETHASONE SODIUM PHOSPHATE; FINASTERIDE; MINOXIDIL; TRETINOIN |
| Active Ingredient Strength | 0 g/100g; g/100g; g/100g; g/100g |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC],Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |